Michael A. Rycyzyn
- Immunology top 5%
- Molecular Biology
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Genetics
- Co-authors
- Charles V. ClevengerNorman W. MillerL. William ClemMelanie R. WilsonGregory W. WarrJohn P. NaftelKerri A. O’MalleyWilliam R. Strohl
- Topics
- Monoclonal and Polyclonal Antibodies Research (7 papers)Immune Cell Function and Interaction (5 papers)Peptidase Inhibition and Analysis (5 papers)
- Journals
- Proceedings of the National Academy of SciencesThe Journal of ImmunologyClinical Cancer Research
- Partner nations
- United StatesBelgiumCanada
In The Last Decade
Michael A. Rycyzyn
26 papers receiving 923 citations
Peers
Comparison fields: 5 of 84
- Immunology 506
- Molecular Biology 416
- Oncology 244
- Radiology, Nuclear Medicine and Imaging 141
- Genetics 78
Countries citing papers authored by Michael A. Rycyzyn
This map shows the geographic impact of Michael A. Rycyzyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Rycyzyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Rycyzyn more than expected).
Fields of papers citing papers by Michael A. Rycyzyn
This network shows the impact of papers produced by Michael A. Rycyzyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Rycyzyn. The network helps show where Michael A. Rycyzyn may publish in the future.
Co-authorship network of co-authors of Michael A. Rycyzyn
This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Rycyzyn. A scholar is included among the top collaborators of Michael A. Rycyzyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Rycyzyn. Michael A. Rycyzyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 18 | |
| 3 | 3 | |
| 4 | 24 | |
| 5 | 9 | |
| 6 | 5 | |
| 7 | 58 | |
| 8 | 5 | |
| 9 | 35 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 130 | |
| 13 | 8 | |
| 14 | 74 | |
| 15 | 5 | |
| 16 | 18 | |
| 17 | 1 | |
| 18 | 19 | |
| 19 | 133 | |
| 20 | 10 |
About Michael A. Rycyzyn
Michael A. Rycyzyn is a scholar working on Immunology, Oncology and Immunology and Allergy, having authored 27 papers that have together received 946 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Immune Cell Function and Interaction (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Immunology (506 citations), Oncology (244 citations) and Radiology, Nuclear Medicine and Imaging (141 citations). Michael A. Rycyzyn has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Charles V. Clevenger, Norman W. Miller, L. William Clem, Melanie R. Wilson, Gregory W. Warr, John P. Naftel, Kerri A. O’Malley, William R. Strohl, Hui Deng and Zhiqiang An. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.